452 related articles for article (PubMed ID: 33483864)
1. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
Shi X; Chen M; Zhang Y
Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
[TBL] [Abstract][Full Text] [Related]
2. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients.
Gutiérrez-Chamorro L; Riveira-Muñoz E; Barrios C; Palau V; Nevot M; Pedreño-López S; Senserrich J; Massanella M; Clotet B; Cabrera C; Mitjà O; Crespo M; Pascual J; Riera M; Ballana E
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578296
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
5. Bone biology and COVID-19 infection: Is ACE2 a potential influence factor?
Tao H; Bai J; Zhang W; Zheng K; Guan P; Ge G; Li M; Geng D
Med Hypotheses; 2020 Nov; 144():110178. PubMed ID: 33254500
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
8. ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.
Azizan E; Brown M
Malays J Pathol; 2020 Dec; 42(3):363-367. PubMed ID: 33361716
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19.
Tuo H; Li W; Tang L; He B; Yao B; Mao P; Tang Q
Int Heart J; 2021; 62(1):148-152. PubMed ID: 33518653
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
11. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
12. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
Parit R; Jayavel S
Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
[TBL] [Abstract][Full Text] [Related]
13. Myocardium injury biomarkers predict prognosis of critically ill coronavirus disease 2019 (COVID-19) patients.
Cao L; Zhang S; Luo X; Wang E; Bai Y; Li Z; Li F; Ma J; Liu H
Ann Palliat Med; 2020 Nov; 9(6):4156-4165. PubMed ID: 33302676
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
15. ACE2 and SARS-CoV-2: Tissue or Plasma, Good or Bad?
Wenzel UO; Kintscher U
Am J Hypertens; 2021 Apr; 34(3):274-277. PubMed ID: 33151267
[No Abstract] [Full Text] [Related]
16. Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.
Samidurai A; Das A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947927
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and Cardiovascular Disease: From Bench to Bedside.
Chung MK; Zidar DA; Bristow MR; Cameron SJ; Chan T; Harding CV; Kwon DH; Singh T; Tilton JC; Tsai EJ; Tucker NR; Barnard J; Loscalzo J
Circ Res; 2021 Apr; 128(8):1214-1236. PubMed ID: 33856918
[TBL] [Abstract][Full Text] [Related]
18. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
Chen L; Li X; Chen M; Feng Y; Xiong C
Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
20. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis.
Poznyak AV; Bezsonov EE; Eid AH; Popkova TV; Nedosugova LV; Starodubova AV; Orekhov AN
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]